AustralianSuper Pty Ltd

Position in LLY — ELI LILLY & Co

CIK 1694164 MELBOURNE, C3

Position in LLY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$563,374,716

+$308,730,873 QoQ

Shares Held

469,702

+69.7% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

2.45%

of 13F equity value

Holder Rank

#132

of 4,621 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AustralianSuper Pty Ltd holds $1,190,287,072 across 9 Drug Manufacturers - General names. LLY ranks #1 (47.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	469,702	$563,374,716
2	GILD	Gilead Sciences, Inc.	1,271,457	$160,635,877
3	BIIB	Biogen Inc.	672,723	$145,348,531
4	BMY	Bristol Myers Squibb Co	2,433,354	$140,209,857
5	ABBV	AbbVie Inc.	426,658	$107,364,219
6	JNJ	Johnson & Johnson	152,900	$38,832,013
7	PFE	Pfizer Inc	968,550	$23,322,684
8	MRK	Merck & Co., Inc.	77,831	$10,001,283

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$563,374,716	469,702	+69.7%	Shares	Sole	2026-08-12
2026-03-31	$254,643,843	276,856	+66.7%	Shares	Sole	2026-05-07
2025-12-31	$178,535,530	166,129	+264.1%	Shares	Sole	2026-02-05
2025-09-30	$34,817,979	45,633	+132.7%	Shares	Sole	2025-11-12
2025-06-30	$15,288,921	19,613	+60.9%	Shares	Sole	2025-08-01
2025-03-31	$10,070,320	12,193	+310.8%	Shares	Sole	2025-05-05
2023-06-30	$1,391,932	2,968	-99.3%	Shares	Sole	2023-07-28
2021-09-30	$97,109,159	420,295	-15.4%	Shares	Sole	2021-11-12
2021-06-30	$113,990,189	496,646	+10.7%	Shares	Sole	2021-08-12
2021-03-31	$83,835,101	448,748	+205.2%	Shares	Sole	2021-05-14
2020-12-31	$24,827,584	147,048	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.